The Discovery Centre is designed to foster collaboration and interaction – helping us accelerate the development of medicines for patients. This state-of-the-art building, the novel technologies and talented scientists it houses, will help us sustain and build the next wave of transformational ...
Completed in 2021 in Cambridge, United Kingdom. Images by Hufton+Crow. AstraZeneca is establishing a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge...
AstraZeneca has established a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge Biomedical Campus (CBC). The CBC plays an important role in the UK and Europe’s leading life sciences cluster. It is a hub...
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn ...
British-Swedish pharmaceutical and biologics company AstraZeneca built a global research and development (R&D) facility, named the Discovery Centre (DISC), at the Cambridge Biomedical Campus (CBC) in Cambridge, UK. The state-of-the-art facility serves as the hub for AstraZeneca’s R&D activities...
AstraZeneca's Discovery Centre by Herzog de Meuron is inaugurated in Cambridge, a new research and development hub with a suitably advanced design
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial ...
The programme is expected to incur $1.4 billion in one-time restructuring charges, of which $800 million are likely to be cash costs. In addition, the company will invest approximately $500 million in establishing the new centre in Cambridge. Annualised benefits of approximately $190 million ...
AstraZeneca has opened a multimillion dollar research facility in Bangalore, India, which will focus on finding new treatments for tuberculosis. AZ previously announced an investment programme for the drug discovery centre in Bangalore, which employs more than 100 scientists.ManufacturingChemistGroup...
form AstraZeneca. In 2000, the company spent approximately USD 134 million to construct a manufacturing plant in Wuxi, Jiangsu, which was completed a year later. As a base for its business in China, AstraZeneca established its Innovation Centre China (ICC) in Zhangjiang Hi-Tech Park in 2007...